Myelodysplastic Syndromes: Practical Tools for Management

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: February 06, 2015
Expiration Date: February 06, 2016

Expected time to complete this activity as designed: 30 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

For most patients, myelodysplastic syndromes (MDS) is an incurable disease due to age or comorbidities. For these patients, appropriate diagnosis, selection of therapeutic strategies based on an accurate risk stratification, and proactive management of adverse events are keys to delaying leukemic transformation and disease progression, and to prolonging survival. In this educational activity, Sandra Kurtin discusses key factors to consider when identifying the most appropriate therapeutic strategy for the individual patient, and critical elements of disease management in both high- and low-risk patients with MDS.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in the management of patients with myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify the goals of therapy in MDS patients, differentiating goals for patients with high- versus low-risk disease
  • Outline strategies for minimizing adverse events in patients with MDS, focusing on proactive strategies which will support continuation of therapy

Agenda

Myelodysplastic Syndromes: Practical Tools for Management – Sandra E. Kurtin, RN, MS, AOCN©, ANP-C

Instructions for Participation and Credit

This activity is eligible for CME credit through February 6, 2016. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME credit may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Sandra E. Kurtin, RN, MS, AOCN©, ANP-C
Clinical Assistant Professor of Medicine
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona Cancer Center
Tucson, Arizona

Sandra Kurtin graduated from the University of Arizona with a bachelor of science in nursing with high distinction, followed by a master of science in oncology nursing, and post-graduate certification in both geriatric and adult practice. She is currently enrolled in the PhD program at the University of Arizona. Ms. Kurtin, clinical assistant professor of medicine, and adjunct clinical assistant professor of nursing at The University of Arizona Cancer Center, has 30 years of oncology nursing experience, 24 of those in advanced practice, and 19 as a nurse practitioner in oncology. She maintains a busy clinical practice in an NCI-designated Comprehensive Cancer Center with expertise in hematological malignancies, GI malignancies, clinical trials, and symptom management.

Ms. Kurtin is a member of the executive committee for the MDS Foundation. She helped to develop the International Nurse Leadership Board for the MDS Foundation which supports MDS patients, their caregivers, and health care professionals worldwide. She is a member of the International Myeloma Foundation Nurse Leadership Board, currently spearheading an online Survivorship Care Plan application for Myeloma Survivors. She is also a founding board member for the Advanced Practitioner Association for Hematology and Oncology (APSHO), and an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS). In addition, Ms. Kurtin serves on a number of editorial boards and as a reviewer for peer-reviewed publications relevant to oncology and supportive care. She is widely published in peer reviewed journals, and she lectures nationally and internationally. Her research focus is on caregivers of cancer survivors using a multimedia telehealth intervention aimed at reducing patient and caregiver symptom burden (in particular fatigue), improving patient and caregiver quality of life, and increasing perceived support in cancer survivors.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-15-005-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Sandra Kurtin has received honoraria as a consultant from Celgene Corporation, Takeda Oncology, and Onyx.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Ms. Kurtin has indicated that she does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Ms. Kurtin has indicated that she does intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@managingmds.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2015 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved